Worg Pharmaceuticals
Hangzhou
About Worg Pharmaceuticals
Worg Pharmaceuticals is a clinical-stage biopharmaceutical company developing new treatments for allergies and other diseases. The company is building a pipeline for allergy and autoimmune diseases based on two technology platforms, PCFiT and Apitope, through internal development and external collaboration with flexible business models. Worg is also developing a platform for molecular allergy diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $282.6M
- Funding stage: Late Stage Venture
- Last round: Series D (Dec 2025)
- Website: worgpharma.com
- Phone: 86-571-85065375
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/worg-pharmaceuticals-104522 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.